Introduction
Beta-amyloid (Aβ), which is a product of the proteolytic cleavage of amyloid precursor protein (APP) by β-and γ-secretases, is one of the major contributors to cognitive decline associated with Alzheimer's disease (AD) (Mattson et al., 2004) . Accumulating evidence suggests that neurotoxicity induced by aggregates of Aβ (oligomers) leads to synaptic loss and subsequent neuronal death (Cummings et al., 1998) . Further, the degradation of nerve growth factor (NGF), a neurotrophic factor that promotes nerve growth, is increased in AD, eventually leading to neuronal degeneration and synapse loss (Cuello and Bruno, 2007) . Therefore, the modulation of Aβ-induced neurotoxicity and of neurotrophic factors has been recognized as an important therapeutic approach for controlling the onset of AD.
In the present study, isorosmanol (Fig. 1A) , a diterpene isolated from rosemary by activityguided fractionation, exhibited a neuroprotective effect against Aβ-induced toxicity in PC12 cells. Interestingly, the neuroprotective effect of isorosmanol was accompanied by a neurotrophic effect in PC12 cells. We found that the neurotrophic effect of isorosmanol was due to the redistribution of F-actin (fi lamentous actin) and the increase of neurofi laments.
Results and Discussion
Aβ (25 -35) has been reported as an active toxic fragment of Aβ (1 -42) (Pike et al., 1991) . Furthermore, and Aβ (1 -42) have been found to induce similar effects on neuritic atrophy and cell death (Tohda et al., 2006) . Therefore, in the present study, Aβ (25 -35) was employed as a neurotoxicant, and the neuroprotective effect of isorosmanol against Aβ-induced toxicity was determined by measuring the viability of PC12 cells The neurotoxicity induced by beta-amyloid (Aβ), which is one of the major causes of Alzheimer's disease (AD), leads to synaptic loss and subsequent neuronal death. Therefore, modulation of Aβ-induced neurotoxicity, as well as regeneration of damaged synapses could be important therapeutic approaches to control AD. In this study, we found that isorosmanol, an abietane-type diterpene, protected PC12 cells against Aβ-induced toxicity. Furthermore, isorosmanol promoted the generation of neurites. The neurotrophic effect of isorosmanol was enhanced by co-treatment with nerve growth factor (NGF). In addition, the neurite outgrowth induced by isorosmanol was accompanied by F-actin redistribution and increased expression of neurofi laments. Taken together, these results suggest that isorosmanol possesses both neuroprotective and neurotrophic effects, that might be benefi cial for controlling AD.
Neuroprotective and Neurotrophic Effects of Isorosmanol
Key words: Isorosmanol, Neurotrophic Effect, Beta-amyloid incubated with Aβ in the absence or presence of isorosmanol using an MTT assay. Treatment with 10 µM Aβ (25 -35) induced approximately 50% cell death (Fig. 1B) . Treatment with isorosmanol alone did not decrease the cell viability when compared to DMSO-treated controls (data not shown). Conversely, pre-treatment with 4, 20 or 100 µg/ml of isorosmanol signifi cantly inhibited the Aβ-induced toxicity in PC12 cells. Particularly, treatment of PC12 cells with 100 µg/ml isorosmanol completely blocked the Aβ-induced toxicity. These results suggest that isorosmanol can protect PC12 cells from Aβ-induced toxicity in a dose-dependent manner.
In addition to the neuroprotective effect against Aβ-induced toxicity, isorosmanol induced the neurite outgrowth in PC12 cells. PC12 cells in DMSO-treated control groups seldom possessed neurites ( Fig. 2A) , whereas there was a signifi cant increase in neurite generation in cells treated with isorosmanol (10 µg/ml), NGF (100 ng / ml), or isorosmanol (10 µg/ml) + NGF (100 ng/ml) (Figs. 2B, C, and D, respectively) compared to the controls. As shown in Fig. 2E , the number of cells possessing neurites longer than the length of the cell body was signifi cantly increased in cells treated with isorosmanol, NGF or isorosmanol + NGF compared to DMSO-treated controls. Furthermore, the cells treated with isorosmanol in the presence of NGF possessed signifi cantly more neurites than cells treated with isorosmanol alone. These results suggest that isorosmanol possesses a neurotrophic effect in PC12 cells that is enhanced by co-treatment with NGF.
The neurotrophic effect of isorosmanol was confi rmed by evaluating the effect of isorosmanol on F-actin redistribution with phalloidin-FITC conjugates. In DMSO-treated control cells, the nuclei were weakly immunostained with phalloidin-FITC conjugates, whereas fl uorescent staining was more evenly distributed in the cytoplasm and the cell membrane (Fig. 2F) . However, treatment with isorosmanol induced concentrated fl uorescent staining at the growth-cone, especially to the neurites (Fig. 2G) . F-actin is one of the principal components of the cytoskeleton in eukaryotic species. In nerve cells, F-actin concentrates in the growth-cone of the axon. NGF induces F-actin redistribution from the cytoplasm to the growthcone where it induces neurite growth (Sano and Iwanaga, 1992) . Consistent with NGF, isorosmanol induced the F-actin redistribution from the cytoplasm and the cell membrane to the growthcone or the neurites. These results indicate that isorosmanol can induce neurites in PC12 cells.
The effects of isorosmanol on neurofi laments were examined by Western blot analysis using antibodies for phosphorylated neurofi lament H (NF-H) and neurofi lament M (NF-M) (SMI31) and total NF-H and NF-M (N52) (Fig. 2H) . DMSO-treated control cells showed weak immunoreactivities, whereas treatment with isorosmanol, NGF or isorosmanol + NGF signifi cantly increased the immunoreactivities of phosphorylated NF-H and NF-M, and total NF-H. The immunoreactivity using SMI31 was the highest in cells treated with isorosmanol in the presence of NGF. Previous reports indicated that NGF generates thin dendritic neurites and concomitantly dramatically increases the protein levels of neurofi laments (NFs) in PC12 cells (Yao et al., 2005) . In addition, NF-L and NF-M are detectable during initial neurite outgrowth, whereas NF-H is signifi cantly expressed later in differentiation (Lee and Cleveland, 1996) . Taken together, these results suggest that isorosmanol induces the generation of neurites by increasing the expression of NFs. However, mechanistic details of neurite outgrowth induced by isorosmanol should be studied further.
In conclusion, our study demonstrates that iso rosmanol can protect PC12 cells against Aβ-induced cytotoxicity. In addition, isorosmanol induces neurotrophic outgrowth in PC12 cells by redistributing F-actin from the cytoplasm to the growth-cone and by increasing the levels of NF proteins. The neurotrophic effect of isorosmanol is further enhanced by co-treatment with NGF. Our results suggest that the neurotrophic and neuroprotective effects of isorosmanol could be benefi cial for the treatment and control of neurodegenerative diseases such as AD.
Material and Methods

Chemicals
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), sodium dodecyl sulfate (SDS), and N,N-dimethyl sulfoxide (DMSO) were purchased from Sigma (St. Louis, MO, USA). Aβ (25 -35) was purchased from Bachem California Inc. (Torrance, CA, USA). Dulbecco's modifi ed Eagle's medium (DMEM), fetal bovine serum (FBS), and horse serum were obtained from Gibco (Logan, UT, USA). Activity-guided fractionation of methanol extracts from rosemary resulted in the isolation of isorosmanol. Isorosmanol was dissolved in DMSO at 1 mg/ml concentration, and stored at -70 °C until use. Aβ (25 -35) used for this study was pre-aggregated prior to use (Park et al., 2008) .
Assessing neuroprotective effects of isorosmanol against Aβ in PC12 cells
The ability of isorosmanol to rescue PC12 cells from Aβ (25 -35)-induced toxicity was determined by measuring the potential of the cells to reduce MTT to MTT formazan (Park et al., 2008) . Briefl y, exponentially growing PC12 rat pheochromocytoma cells (4 · 10 4 cells per well) were pre-treated with different concentrations of isorosmanol (0.8, 4, 20, and 100 µg/ml) for 1 h, followed by treatment with Aβ (25 -35) (10 µM) for an additional 24 h. Then, MTT solution (10 µl per well, 5 mg/ml stock solution in PBS) was added for 3 h at 37 °C. The cells were then lysed in the presence of 100 µl of lysis buffer (10% w/v of SDS in 0.01 M HCl) overnight at 37 °C. Next, the optical density of the resulting solutions was colorimetrically determined at 570 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA).
Determination of neurite outgrowth
PC12 cells plated on collagen-coated cover glasses were incubated with isorosmanol (10 µg / ml), NGF (100 ng/ml), or isorosmanol (10 µg/ml) + NGF (100 ng/ml) for 24 h, after which the cells were fi xed with 4% paraformaldehyde (pH 7.4). The number of cells possessing neurites longer than the length of the cell body was counted under a Nikon inverted microscope.
Determination of F-actin redistribution
PC12 cells cultured on collagen-coated cover glasses were incubated with or without isorosmanol (10 µg/ml) for 24 h. Then, the cells were fi xed with 4% paraformaldehyde (pH 7.4) and permeabilized with 0.1% Triton X-100. After blocking with 10% bovine serum albumin, the cells were incubated with fl uorescent phalloidin-FITC conjugates (1:2000; Sigma) for 2 h at room temperature. After several washes in phosphate buffered saline (PBS), the cells were mounted on glass slides. Pictures were taken under a Nikon fl uorescence microscope.
Protein determination, electrophoresis, and immunoblotting
PC12 cells treated with isorosmanol (10 µg/ ml) in the presence or absence of NGF (100 ng/ ml) for 24 h were scraped into sample buffer and homogenized in a boiling water bath for 10 min. After determination of the protein concentrations by Lowry's method, proteins were separated on SDS-PAGE gels and transferred to Immobilon membranes (Millipore, Billerica, MA, USA). Immunodetection was performed according to Towbin et al. (1979) . The following antibodies were used: phosphorylated neurofi lament-H (NF-H) and neurofi lament-M (NF-M) (clone SMI31; 1:2000; Sternberger Monoclonals, Baltimore, MD, USA), phosphorylated and non-phosphorylated NF-H (clone N52; 1:1000; Sigma) and tubulin (1:10,000; Sigma). Secondary anti-mouse IgG antibodies (1:1000; Santa Cruz, Santa Cruz, CA, USA) followed by enhanced chemiluminescence reagents (Amersham Biosciences, Piscataway, NJ, USA) were used for the detection of proteins. Densitometric values were normalized using tubulin as an internal control. Scanning of the Western blots confi rmed that the curve was linear in the range used for each antibody.
Data analysis
Data in text and fi gures are expressed as means ± SD. Two-group comparisons were evaluated with Student's t-tests. Differences were considered statistically signifi cant at p < 0.05.
